Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

Three drug companies and the Association of National Advertisers have sued HHS in an attempt to block implementation of a CMS rule requiring list price disclosures in direct-to-consumer

Read the full 289 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE